<?xml version="1.0" encoding="UTF-8"?>
<ref id="B154-molecules-26-00632">
 <label>154.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Verma</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Twilley</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Esmear</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Oosthuizen</surname>
    <given-names>C.B.</given-names>
   </name>
   <name>
    <surname>Reid</surname>
    <given-names>A.-M.</given-names>
   </name>
   <name>
    <surname>Nel</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lall</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)</article-title>
  <source>Front. Pharmacol.</source>
  <year>2020</year>
  <volume>11</volume>
  <fpage>561334</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2020.561334</pub-id>
  <?supplied-pmid 33101023?>
  <pub-id pub-id-type="pmid">33101023</pub-id>
 </element-citation>
</ref>
